Annelies Leemans Selected Research

Respiratory Syncytial Virus Infections

1/2019	Characterization of the role of N-glycosylation sites in the respiratory syncytial virus fusion protein in virus replication, syncytium formation and antigenicity.
1/2017	Respiratory syncytial virus (RSV) entry is inhibited by serine protease inhibitor AEBSF when present during an early stage of infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Annelies Leemans Research Topics

Disease

3	Infections 01/2019 - 01/2017
2	Respiratory Syncytial Virus Infections 01/2019 - 01/2017
1	Human Influenza (Influenza) 01/2017
1	Visceral Leishmaniasis (Kala Azar) 01/2015

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2018
2	Neutralizing AntibodiesIBA 01/2019 - 01/2018
2	VaccinesIBA 01/2019 - 01/2018
1	Peptides (Polypeptides)IBA 01/2019
1	Polysaccharides (Glycans)IBA 01/2019
1	pepstatin (pepstatin A)IBA 01/2017
1	Peptide Hydrolases (Proteases)FDA Link 01/2017
1	4-(2-aminoethyl)benzenesulfonylfluoride (AEBSF)IBA 01/2017
1	E 64IBA 01/2017
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2017
1	Aprotinin (Trasylol)FDA Link 01/2017
1	Tosylphenylalanyl Chloromethyl Ketone (TPCK)IBA 01/2017
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2017
1	Paromomycin (Paromomycin Sulfate)FDA LinkGeneric 01/2015